Immune Recovery Uveitis: Why Eye Inflammation Can Start After HIV Treatment Begins
Immune Recovery Uveitis at a Glance
Call your eye doctor the same day if your sight changes after you start HIV treatment. Most of these changes can be treated. Acting fast keeps the odds in your favor.
- New floaters, or a sudden shower of specks in your sight
- Blurred or decreased vision in either eye
- A dark shadow or curtain over part of your sight
- Severe eye pain, or an eye that is red and painful
- New light sensitivity, so normal light hurts
These signs can come from immune recovery uveitis. They can also come from an active CMV infection in the retina, or from a torn retina. In pooled studies of people with CMV retinitis, blurred vision was the most commonly reported symptom, in about 55 of every 100, and retinal detachment was observed in about 24 of every 100 over the entire course of the disease.1 So a new eye symptom is worth a dilated eye exam soon. An eye doctor can sort these causes apart at one visit. Keep taking your HIV medicine while you wait; do not stop it on your own.
It is swelling (clinical: inflammation) inside the eye that starts after your immune system gets stronger again. It occurs in eyes already scarred by CMV retinitis, a retinal infection caused by cytomegalovirus, and appears once HIV therapy restores immune function; the swelling is not a new infection, and it is treated with steroid (clinical: corticosteroid) medicine while your HIV therapy continues.2
The name splits neatly in two. 'Immune recovery' means your CD4 count is climbing, which is the goal of treatment. 'Uveitis' means swelling inside the eye. Uveitis of any cause tends to show up as eye redness, light sensitivity, blurry vision or new floaters, and the American Academy of Ophthalmology advises contacting an ophthalmologist right away when those symptoms appear.3
This part feels backwards, and understanding it changes how you read your own symptoms. While your CD4 count was very low, your immune system could not fight much anywhere, so CMV damaged the retina quietly. Once treatment restores those immune cells, they reach the eye and react to leftover viral material in the scarred tissue.
The reaction appears to be an inflammatory response to cytomegalovirus material left in the eye rather than to a spreading infection, and it is managed by calming the swelling with corticosteroids while the HIV therapy that produced the immune recovery is continued.2 Your HIV treatment working is a precondition for this problem, not a failure of it. Many people read new eye trouble as the medicine failing and stop taking it, which would not settle the eye and would open the door to a fresh retinal infection. Phone your HIV clinician and your eye doctor instead.
Estimates vary widely between clinics, so treat any single number with care. Pooling 28 studies of 3,748 people with CMV retinitis, immune recovery uveitis occurred in about 26 of every 100 after HIV therapy started, with an uncertainty range around that pooled figure of about 19 to 34 of every 100.1 A 19-center United States cohort of 374 people with AIDS and CMV retinitis found it in 36 people, about 10 of every 100, rising to about 18 of every 100 among those whose CD4 count recovered after the retinitis was found.4 So it is common enough that your eye team should watch for it by name, and uncommon enough that most people never get it. Neither figure predicts your own eyes. What they justify is keeping your appointments through the first year or two of treatment.
What Happens Inside the Eye When the Immune System Returns
This condition nearly always follows CMV retinitis, so the story starts there. CMV retinitis risk climbs sharply once the CD4 count drops below 50 cells per microliter. It is found by a dilated exam of the back of the eye, and treated with valganciclovir or ganciclovir, often with injections of medicine into the eye.5 The infection leaves scarred retina and traces of virus behind, and that scarred tissue is what your returning immune cells later react to.
So your eye doctor will want the history: when the retinitis was found, how much retina it covered, and whether it came back. A larger area of old retinitis is linked to a higher chance of swelling later.
No one can predict this for one person. Research has found patterns that shift the odds, and your team weighs them when deciding how closely to watch.
- A CD4 count that climbs back to about 100 cells per microliter or higher
- A large area of retina affected by the old infection
- Cidofovir given as an injection into the eye for the earlier retinitis
Reported risk factors include a CD4 count that climbs to about 100 cells per microliter or higher, a larger area of retina affected by the old CMV infection (eyes with more than about a third of the retina involved carried roughly 4.5 times the risk reported for eyes with under about a fifth involved), and cidofovir injected into the eye, which was linked with roughly 19 times the reported risk; the reported median time from starting HIV therapy to this uveitis has ranged from about 20 to 43 weeks.2 In one 30-patient series the median CD4 count was 20 cells per microliter at HIV diagnosis and 210 by the time this uveitis was found.6
The difference matters because the treatments point in opposite directions. Swelling calls for steroids. Active infection calls for antiviral medicine. Only an eye exam can tell them apart, and sometimes a sample of fluid from inside the eye is needed.
| What your doctor checks | Immune recovery uveitis | Active CMV retinitis |
|---|---|---|
| State of the retina | Old scarring, no advancing edge | New white patches, sometimes bleeding |
| CD4 count | Recovered, often above 100 | Usually still very low |
| Main treatment | Steroids, HIV therapy continued | Antiviral medicine, urgent |
A four-patient case series described active CMV retinitis with heavy swelling in the jelly of the eye within 8 weeks of starting HIV therapy, as CD4 counts rose from a mean of about 15 to about 183 cells per microliter.7 That is a very small report, so read it as a caution rather than a rule: early swelling still needs an eye doctor.
Symptoms of Immune Recovery Uveitis and How They Feel
Most people notice floaters or a drop in sharpness first. It often builds over days to weeks rather than suddenly, which is one reason it gets brushed off.
- Floaters: specks, threads or cobwebs drifting across your sight
- Blurred vision, or vision that seems dim or washed out
- Trouble reading small print or seeing faces clearly
- Aching, redness or light sensitivity if the front of the eye is involved
People with this condition most often report floaters and reduced vision, with acuity commonly between 20/40 and 20/200, and the swelling may involve the front of the eye, the jelly, the optic disc, or the macula.2 If the earlier retinitis already limited your vision, compare each eye on its own by covering one at a time.
Where the swelling sits shapes what you feel and how it is treated, and your eye doctor will use these words.
- Anterior uveitis: the front chamber, causing redness, ache and light sensitivity
- Vitritis: the jelly that fills the eye, causing floaters and haze
- Cystoid macular edema: fluid pockets blurring central vision
- Papillitis: swelling of the optic nerve head
In a 30-patient Singapore series, 27 of 53 eyes had both anterior uveitis and vitritis, 22 of 53 had anterior uveitis alone, and 23 of the 30 people had both eyes affected.6 Central blurring usually points to fluid in the macula, the finding most closely tied to lasting vision loss, so it is checked at every visit.
Other problems cause floaters and blurring after treated CMV retinitis: the retinitis restarting, a retinal detachment, another infection inside the eye, or a cataract clouding vision slowly. Retinal detachment was observed in about 24 of every 100 people over the entire course of CMV retinitis across pooled studies, and about 29 of every 100 had no symptoms when their retinitis was found.1 That is why an exam, not your symptoms alone, drives the diagnosis.
How Doctors Diagnose Immune Recovery Uveitis
The heart of the diagnosis is an eye doctor looking inside your eye with the pupil widened by drops. No blood test settles it. Expect a couple of hours, and arrange not to drive home.
Your doctor measures your vision, checks the eye pressure, looks for inflammatory cells at the slit lamp, then examines the retina. A dilated exam of the back of the eye is the standard way CMV retinitis and its complications are identified.5 They want two answers: how much swelling is present, and whether the old retinitis has restarted.
Fluid in the macula drives most of the vision loss here, so imaging is part of nearly every visit. Optical coherence tomography, usually called OCT, scans a cross-section of the retina in seconds without touching your eye.
OCT shows fluid pockets an exam can miss, and gives a number your team tracks over time. Cystoid macular edema is the complication most strongly linked with vision loss in immune recovery uveitis, and epiretinal membrane is another recognized complication.2 Ask to see your own scan; watching the fluid shrink is the clearest sign treatment is working.
Your eye doctor and HIV clinician need to share numbers, because the condition is defined partly by the immune recovery itself.
The label is generally used when someone with previously treated CMV retinitis develops swelling inside the eye while on effective HIV therapy, with a CD4 count that has risen above roughly 100 cells per microliter, and no other cause explains it.2 Bring recent CD4 and viral load results to the eye appointment, or ask that they be sent across. It saves a visit.
Treatment Choices for Immune Recovery Uveitis
Steroids are the mainstay. The route depends on where the swelling sits, and your team starts with the least invasive option that reaches it.
| Route | Usually used for | What to know |
|---|---|---|
| Steroid eye drops | Swelling in the front of the eye | Frequent at first, then tapered |
| Injection around the eye | Macular fluid, hazy jelly | Numbed first; lasts weeks to months |
| Injection or implant inside the eye | Fluid that keeps coming back | Longer acting; raises cataract and pressure risk |
Reported responses are partial rather than complete: in one report, depot steroid injections given around the eye appeared to reduce inflammatory cells in the jelly in about 60 of every 100 treated eyes, had a lesser effect on sight, which improved in only about 40 of every 100, and macular fluid was resistant to steroid injections in some eyes.2 Improvement is common, a full return of vision is not something anyone can promise, and repeat treatments are often needed.
The usual plan keeps HIV therapy going, because stopping it would undo the immune recovery. Anti-CMV medicine may be restarted or kept going while steroids are used, since steroids damp the immune response now holding the virus in check.
To guard against CMV reactivating after corticosteroid treatment, some authors recommend restarting anti-CMV therapy, and the antiretroviral therapy that produced the immune recovery is continued rather than stopped.2 Long-term anti-CMV maintenance is generally stopped only after the immune system has recovered and the retinitis is inactive, and even then the retinitis came back in about 16 of every 100 people across pooled studies.1 That decision belongs to your HIV clinician and eye doctor together, never to a page like this one.
Surgery is not the first answer, and most people never need it. It comes up when scar tissue distorts vision, when haze in the jelly does not clear, or when the retina detaches.
A vitrectomy removes the jelly and peels any membrane off the macular surface. Vitrectomy with membrane peeling improved vision in three of four eyes in one small report, although macular fluid remained afterwards in some cases.2 Those are tiny numbers, so treat surgery as an option to discuss. Ask your surgeon what problem the operation is meant to fix, and what will still be there afterwards.
Progress is judged on three measures: cells and haze graded at the slit lamp, macular fluid on OCT compared with earlier scans, and your vision measured the same way each visit. Swelling settles slowly, and vision often lags weeks behind the exam findings. If two of the three improve and one does not, that common pattern usually prompts an adjustment rather than a new plan.
Complications and the Vision Outlook Over Time
The swelling causes some problems and the treatments cause others. Knowing which is which helps you weigh choices instead of feeling everything is going wrong at once.
- Cystoid macular edema, the main threat to central vision
- Epiretinal membrane, a scar sheet that wrinkles the retina
- Cataract, from the swelling and from steroid treatment
- Raised eye pressure and glaucoma, mainly from steroid treatment
- Retinal detachment, which needs prompt surgery
In the 30-patient Singapore series, 21 of 53 eyes developed a complication, most often cataract in 14 of those eyes, followed by glaucoma or raised pressure in 7.6 Cataract and pressure rises are both manageable, and your team screens for them at routine visits because they respond well early.
Vision outcomes here are mixed rather than uniformly bad, and they depend heavily on whether macular fluid settles.
In the Singapore series, 14 of 53 eyes lost one or more lines of vision by six months, while the rest held steady or improved.6 Read that as a group pattern, not a forecast for you. Your own outlook turns on how much retina the earlier infection destroyed and how quickly the swelling is treated. Old retinitis damage does not reverse, but swelling added on top of it often does settle.
This condition is best known in HIV care, but the same mechanism can follow any recovery of a suppressed immune system after CMV retinitis. It has been reported outside HIV, including in a woman treated for acute myeloid leukemia whose macular swelling followed a reduction in her immune-suppressing therapy after earlier CMV retinitis, and settled for a year after an implant was placed in the eye.8 That is a single case report, so it shows the pattern is possible rather than how often it happens. Similar cases have been described after transplants.
Follow-Up Care and When to Call Your Eye Doctor
Some symptoms should move you to the phone rather than the next scheduled appointment. None means your sight is lost. They mean the cause needs identifying quickly.
- A sudden shower of new floaters, or flashing lights
- A curtain or shadow moving across your field of view
- A sudden drop in vision over hours
- Severe eye pain with redness
The first three raise the question of retinal detachment, which surgery can repair when caught early. The last points to severe swelling or raised eye pressure. Say on the phone that you have had CMV retinitis and are on HIV treatment, because that history moves you up the queue.
Routine checks catch this before symptoms bite, and the interval depends mostly on your CD4 count. Your own schedule should be set by your eye doctor, not by a table on a webpage.
Dilated screening exams are commonly advised about every 2 to 3 months while the CD4 count stays below 50 cells per microliter, with longer gaps as the count rises.5 After CMV retinitis has been treated, many teams keep seeing you regularly through the first year or two of HIV therapy, which is when this uveitis most often appears.
A one-minute home check catches changes you would otherwise miss, especially when your better eye compensates for the other. Cover one eye, look at a doorframe or window edge, then swap eyes, and note whether straight lines look bent or a patch looks blurred. Do it at the same time of day, in the same light, and write down anything that changes.
An Amsler grid, a printed square of fine lines, does the same job more precisely, and your clinic can give you one. Home checks cannot see the back of your eye, so they do not replace exams. They tell you when to bring an appointment forward.
Common Questions About Immune Recovery Uveitis
No, it means close to the opposite. This swelling appears because your immune system is recovering, which is what HIV therapy is meant to achieve. Your returning immune cells react to leftover viral material in retina that CMV damaged earlier. The eye problem is real and needs treating, but it follows success rather than failure. Do not stop your HIV medicine over it; call your eye doctor instead.
The usual window is months rather than days. Across reports, the median interval from starting HIV therapy to the onset of swelling has ranged from roughly 20 to 43 weeks, and some cases appear later still. Swelling in the first few weeks is more likely to be active CMV retinitis, which changes the treatment completely. Either way, new eye symptoms deserve an exam rather than a wait.
Sometimes partly, and it depends on what is causing the loss. Vision lost to swelling and macular fluid often improves once the swelling settles, though improvement is frequently partial and can take months. Vision lost to retina that CMV destroyed earlier does not return, because that tissue is scarred. Your eye doctor can usually tell you which part falls into which category after examining you and reading your scans.
No. The swelling is your own immune system reacting inside your own eye, and nothing about it passes to anyone else. Cytomegalovirus itself is very common, and most people who carry it never become ill from it. It causes retinitis almost only in people whose immune systems are severely weakened. Normal contact and sharing a household carry no risk of passing on this eye condition.
Usually yes, for a period your two clinicians agree on together. Nobody can give you a fixed number of months from a webpage, because the answer depends on your retinal exam and your CD4 trend rather than the calendar. Ask at each visit whether the criteria for stopping have been met, and what is still holding the decision back. Flag missed doses honestly.
It is a real concern, and it is why anti-CMV cover and closer follow-up often go alongside steroid treatment. Steroids calm swelling by damping immune activity, and that same effect could in theory let the virus reactivate. A common approach is the smallest effective steroid dose, anti-CMV therapy restarted or kept running, and more frequent retinal exams. Report new floaters or vision changes promptly while you are on steroids.
More Questions People Ask After This Diagnosis
This swelling follows the old CMV damage, so it appears in eyes that had retinitis. If only one eye was infected, usually only that eye becomes inflamed. Both eyes are affected in many people, because CMV retinitis often involved both: in one 30-patient series, 23 of the 30 had both eyes involved. Your other eye still needs examining each visit, since retinitis can appear there later.
Most people describe pressure rather than pain. The surface of the eye is numbed with drops or gel first, and often with a small anesthetic injection, so the injection itself is brief. Afterwards you may see floaters from the medicine, feel gritty for a day, and have a small red patch on the white of the eye. Ask for a step-by-step description beforehand if the idea worries you.
No supplement has been shown to treat immune recovery uveitis, and none should replace steroid or antiviral treatment. Eye supplements studied for other conditions, such as macular degeneration formulas, were tested in different patients for a different problem, so those results do not transfer here. Tell your clinicians about anything you take, because some products interact with HIV or anti-CMV medicines.
Care usually sits with a retina or uveitis specialist working alongside your HIV clinician, rather than a general eye clinic alone. This condition sits where infection, immunology and retinal disease meet, and the treatment choices trade off against each other. If you are seen only by an optometrist or general ophthalmologist, ask directly about referral to a retina or uveitis service.
- Is the swelling in my eye immune recovery uveitis, or has my CMV retinitis become active again?
- Is there fluid in my macula on the scan, and can you show me?
- How much of my vision loss is from old scarring, and how much from swelling that might settle?
- Which steroid treatment do you recommend, and why that route?
- Will I stay on anti-CMV medicine while I am on steroids?
- What changes in my vision should make me call you before my next appointment?
- How often will you examine me, and who talks to my HIV clinician?
- Frontiers in Cellular and Infection Microbiology (2023). Clinical features of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy (systematic review and meta-analysis of 236 studies, 20,214 patients).
- Mediators of Inflammation (2014). Immune Recovery Uveitis: Pathogenesis, Clinical Symptoms, and Treatment (narrative review).
- American Academy of Ophthalmology, EyeSmart (2025). What Is Uveitis?.
- Ophthalmology (Longitudinal Study of the Ocular Complications of AIDS) (2006). Risk of Immune Recovery Uveitis in Patients with AIDS and Cytomegalovirus Retinitis (19-center cohort, 374 patients, 539 eyes).
- Annals of Eye Science (2022). Cytomegalovirus retinitis in the highly active anti-retroviral therapy era (narrative review).
- Journal of Ophthalmic Inflammation and Infection (2016). Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy: a 5-year study from Singapore (30 patients, 53 eyes).
- Frontiers in Medicine (2022). Cytomegalovirus immune recovery retinitis after initiation of highly active antiretroviral therapy: a case series of four patients.
- Journal of Ophthalmic Inflammation and Infection (2024). Fluocinolone intravitreal implant for macular edema secondary to immune recovery uveitis in a patient with acute myeloid leukemia (case report).